FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950849905> ?p ?o ?g. }

• W2950849905 endingPage "153" @default.
• W2950849905 startingPage "145" @default.
• W2950849905 abstract "Patients with primary biliary cholangitis (PBC) exhibit reduced AE2/SLC4A2 gene expression in the liver and peripheral blood mononuclear cells (PBMCs). AE2 encodes a Cl-/HCO3- exchanger involved in biliary bicarbonate secretion and intracellular pH regulation. Reduced AE2 expression in PBC may be pathogenic, as Ae2-knockout mice reproduce characteristic PBC features. Herein, we aimed to identify CpG-methylation abnormalities in AE2 promoter regions that might contribute to the reduced gene transcription in PBC livers and PBMCs.CpG-cytosine methylation rates were interrogated at 1-base pair resolution in upstream and alternate AE2 promoter regions through pyrosequencing of bisulphite-modified genomic DNA from liver specimens and PBMCs. AE2a and alternative AE2b1 and AE2b2 mRNA levels were measured by real-time PCR. Human lymphoblastoid-T2 cells were treated with 5-aza-2´-deoxycytidine for demethylation assays.AE2 promoters were found to be hypermethylated in PBC livers compared to normal and diseased liver specimens. Receiver operating characteristic (ROC) curve analysis showed that minimal CpG-hypermethylation clusters of 3 AE2a-CpG sites and 4 alternate-AE2b2-CpG sites specifically differentiated PBC from normal and diseased controls, with mean methylation rates inversely correlating with respective transcript levels. Additionally, in PBMCs a minimal cluster of 3 hypermethylated AE2a-CpG sites distinguished PBC from controls, and mean methylation rates correlated negatively with AE2a mRNA levels in these immune cells. Alternate AE2b2/AE2b1 promoters in PBMCs were constitutively hypermethylated, in line with absent alternative mRNA expression in diseased and healthy PBMCs. Demethylation assays treating lymphoblastoid-T2 cells with 5-aza-2´-deoxycytidine triggered AE2b2/AE2b1 expression and upregulated AE2a-promoter expression.Disease-specific hypermethylation of AE2 promoter regions and subsequent downregulation of AE2-gene expression in the liver and PBMCs of patients with PBC might be critically involved in the pathogenesis of this complex disease.Primary biliary cholangitis (PBC) is a chronic immune-associated cholestatic liver disease with unclear complex/multifactorial etiopathogenesis affecting mostly middle-aged women. Patients with PBC exhibit reduced expression of the AE2/SLC4A2 gene. Herein, we found that AE2 promoter regions are hypermethylated in the liver and peripheral blood mononuclear cells of patients with PBC. This increased methylation is associated with downregulated AE2-gene expression, which might contribute to the pathogenesis of PBC. Therefore, novel epigenetic targets may improve treatment in patients with PBC who respond poorly to current pharmacological therapies." @default.
• W2950849905 created "2019-06-27" @default.
• W2950849905 creator A5002412589 @default.
• W2950849905 creator A5027743895 @default.
• W2950849905 creator A5027862163 @default.
• W2950849905 creator A5042308000 @default.
• W2950849905 creator A5049374200 @default.
• W2950849905 creator A5075950171 @default.
• W2950849905 creator A5083542745 @default.
• W2950849905 date "2019-09-01" @default.
• W2950849905 modified "2023-10-10" @default.
• W2950849905 title "Promoter hypermethylation of the AE2/SLC4A2 gene in PBC" @default.
• W2950849905 cites W1488397342 @default.
• W2950849905 cites W1571666099 @default.
• W2950849905 cites W1617522034 @default.
• W2950849905 cites W1736292287 @default.
• W2950849905 cites W1926762970 @default.
• W2950849905 cites W1964344120 @default.
• W2950849905 cites W1965928933 @default.
• W2950849905 cites W1966382491 @default.
• W2950849905 cites W1968447938 @default.
• W2950849905 cites W1972008427 @default.
• W2950849905 cites W1976590910 @default.
• W2950849905 cites W1981904875 @default.
• W2950849905 cites W1985444222 @default.
• W2950849905 cites W1990328983 @default.
• W2950849905 cites W2013367705 @default.
• W2950849905 cites W2018046629 @default.
• W2950849905 cites W2019481852 @default.
• W2950849905 cites W2021497385 @default.
• W2950849905 cites W2026300620 @default.
• W2950849905 cites W2032387601 @default.
• W2950849905 cites W2039030896 @default.
• W2950849905 cites W2050252182 @default.
• W2950849905 cites W2057053458 @default.
• W2950849905 cites W2059378625 @default.
• W2950849905 cites W2059951928 @default.
• W2950849905 cites W2063118624 @default.
• W2950849905 cites W2063975050 @default.
• W2950849905 cites W2067983267 @default.
• W2950849905 cites W2071213636 @default.
• W2950849905 cites W2083605128 @default.
• W2950849905 cites W2085749465 @default.
• W2950849905 cites W2087870990 @default.
• W2950849905 cites W2088633095 @default.
• W2950849905 cites W2103877699 @default.
• W2950849905 cites W2107277218 @default.
• W2950849905 cites W2114006962 @default.
• W2950849905 cites W2120698555 @default.
• W2950849905 cites W2124001862 @default.
• W2950849905 cites W2134613519 @default.
• W2950849905 cites W2134720739 @default.
• W2950849905 cites W2137821085 @default.
• W2950849905 cites W2140245797 @default.
• W2950849905 cites W2140803622 @default.
• W2950849905 cites W2149506940 @default.
• W2950849905 cites W2153174384 @default.
• W2950849905 cites W2153364732 @default.
• W2950849905 cites W2156640455 @default.
• W2950849905 cites W2161458396 @default.
• W2950849905 cites W2167534755 @default.
• W2950849905 cites W2170984819 @default.
• W2950849905 cites W2192080449 @default.
• W2950849905 cites W2193621019 @default.
• W2950849905 cites W2299768272 @default.
• W2950849905 cites W2508283869 @default.
• W2950849905 cites W2605875188 @default.
• W2950849905 cites W2608398590 @default.
• W2950849905 cites W2613093638 @default.
• W2950849905 cites W2754683187 @default.
• W2950849905 cites W2806453263 @default.
• W2950849905 cites W3112051670 @default.
• W2950849905 cites W49408137 @default.
• W2950849905 doi "https://doi.org/10.1016/j.jhepr.2019.05.006" @default.
• W2950849905 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7001545" @default.
• W2950849905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32039364" @default.
• W2950849905 hasPublicationYear "2019" @default.
• W2950849905 type Work @default.
• W2950849905 sameAs 2950849905 @default.
• W2950849905 citedByCount "11" @default.
• W2950849905 countsByYear W29508499052019 @default.
• W2950849905 countsByYear W29508499052020 @default.
• W2950849905 countsByYear W29508499052021 @default.
• W2950849905 countsByYear W29508499052022 @default.
• W2950849905 countsByYear W29508499052023 @default.
• W2950849905 crossrefType "journal-article" @default.
• W2950849905 hasAuthorship W2950849905A5002412589 @default.
• W2950849905 hasAuthorship W2950849905A5027743895 @default.
• W2950849905 hasAuthorship W2950849905A5027862163 @default.
• W2950849905 hasAuthorship W2950849905A5042308000 @default.
• W2950849905 hasAuthorship W2950849905A5049374200 @default.
• W2950849905 hasAuthorship W2950849905A5075950171 @default.
• W2950849905 hasAuthorship W2950849905A5083542745 @default.
• W2950849905 hasBestOaLocation W29508499051 @default.
• W2950849905 hasConcept C101762097 @default.
• W2950849905 hasConcept C104317684 @default.
• W2950849905 hasConcept C137061746 @default.
• W2950849905 hasConcept C140173407 @default.

• next